Adolescents prefer long-acting injectables to daily oral HIV treatment, study finds
Almost two-thirds of new HIV cases occur outside southern and eastern Africa
Top 5 stories on HIV in the US from CROI 2024
People who inject drugs in the US are more aware of PrEP, but aren’t taking it
Top 5 stories on injectable HIV treatment and PrEP from CROI 2024
Over 30 years, big fall in HIV among people who inject drugs in Baltimore, but hepatitis C remains high
Top 5 stories on HIV and women from CROI 2024
Top 5 HIV PrEP stories from CROI 2024
Long-acting injectables can be a good option for people with adherence challenges
